Docoh
Loading...

AXDX Accelerate Diagnostics

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

Company profile

Ticker
AXDX
Exchange
CEO
John Phillips
Employees
Incorporated
Location
Fiscal year end
Former names
ACCELR8 TECHNOLOGY CORP
SEC CIK
IRS number
841072256

AXDX stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

7 May 21
4 Aug 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 42.73M 42.73M 42.73M 42.73M 42.73M 42.73M
Cash burn (monthly) (positive/no burn) (positive/no burn) 8.08M 6.76M 4.46M 3.85M
Cash used (since last report) n/a n/a 33.44M 27.98M 18.45M 15.92M
Cash remaining n/a n/a 9.29M 14.74M 24.27M 26.8M
Runway (months of cash) n/a n/a 1.1 2.2 5.4 7.0

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
22 Jun 21 Phillips Jack Common Stock Sell Dispose S No No 7.94 23,479 186.42K 112,698
22 Jun 21 Phillips Jack Common Stock Option exercise Aquire M No No 0 62,160 0 136,177
22 Jun 21 Phillips Jack RSU Common Stock Option exercise Dispose M No No 0 62,160 0 124,320
20 May 21 Phillips Jack RSU Common Stock Grant Aquire A No No 0 206,597 0 206,597
20 May 21 Brown Thomas D Stock Option Common Stock Grant Aquire A No No 7.68 35,168 270.09K 35,168
20 May 21 Strobeck Matthew Stock Option Common Stock Grant Aquire A No No 7.68 35,168 270.09K 35,168
20 May 21 Francesconi Louise Stock Option Common Stock Grant Aquire A No No 7.68 35,168 270.09K 35,168

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

36.8% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 100 2 +4900.0%
Opened positions 99 0 NEW
Closed positions 1 111 -99.1%
Increased positions 0 2 EXIT
Reduced positions 1 0 NEW
13F shares
Current Prev Q Change
Total value 221.26M 17.67M +1152.0%
Total shares 22.44M 9.35M +140.1%
Total puts 243.4K 0 NEW
Total calls 122.3K 0 NEW
Total put/call ratio 2.0
Largest owners
Shares Value Change
Oracle Investment Management 3.78M $31.42M NEW
BLK Blackrock 2.37M $19.73M NEW
AXAHF Axa 1.63M $13.53M NEW
Vanguard 1.61M $13.39M NEW
Chicago Capital 1.59M $13.26M NEW
Griffin Asset Management 1.36M $11.3M NEW
Cannell Peter B & Co 1.1M $9.13M NEW
Baird Financial 984.74K $8.19M NEW
Blair William & Co 854.23K $7.11M NEW
STT State Street 803.24K $6.68M NEW
Largest transactions
Shares Bought/sold Change
Cowen Prime Services 0 -7.58M EXIT
Oracle Investment Management 3.78M +3.78M NEW
BLK Blackrock 2.37M +2.37M NEW
AXAHF Axa 1.63M +1.63M NEW
Vanguard 1.61M +1.61M NEW
Chicago Capital 1.59M +1.59M NEW
Griffin Asset Management 1.36M +1.36M NEW
Cannell Peter B & Co 1.1M +1.1M NEW
Baird Financial 984.74K +984.74K NEW
CS Credit Suisse 792.97K -972.42K -55.1%

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: add, agree, agreed, analytical, ancillary, assigned, assignment, bad, Brown, budget, case, clarity, cutting, deadly, enhanced, examination, format, franchise, growing, herd, hesitancy, hospitalization, immunity, impeding, Incentive, IRS, Jack, John, lesser, main, Matthew, Miller, NaN, Patience, placement, President, pursue, reconciled, retail, Schuler, Simplification, Strobeck, tabular, taxable, understanding, vaccination
Removed: achieve, adjusted, amending, analyzer, approval, assay, assuming, attempt, BioCheck, blood, built, carryback, categorical, certificate, chemiluminescence, clarify, collected, comparative, corporation, cumulative, curtail, curve, deduct, Denver, depositor, detection, detrimental, disruption, diversion, economy, effort, emergency, Enterobacteriaceae, exposed, fast, fiduciary, fixed, floating, forecasted, fulfillment, fungal, harm, hinder, historically, hypothetical, IgG, IgM, immunoassay, increasing, incrementally, Institute, insurance, invoiced, LICENSE, limit, liquidating, local, maintained, manage, maturation, maximize, mitigated, move, National, nationwide, operate, overwhelmed, package, point, policy, potential, predominantly, preservation, previously, production, productivity, prospectively, range, recognizing, regulatory, reinvestment, reliable, remotely, removal, reputation, response, retrospectively, Reversal, safety, seek, sensitive, serology, spending, strategic, sweeping, tiered, transacted, utilization, variety, work, workforce, working

Patents

GRANT
Utility
Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing
3 Aug 21
Disclosed are optical interrogation apparatus that can produce lens-free images using an optoelectronic sensor array to generate a holographic image of sample objects, such as microorganisms in a sample.
GRANT
Utility
Sensitive and rapid determination of antimicrobial susceptibility
6 Jul 21
The present invention relates to moving microorganisms to a surface, where they are grown in the presence and absence of antimicrobials, and by monitoring the growth of the microorganisms over time in the two conditions, their susceptibility to the antimicrobials can be determined.
APP
Utility
Instrument and Methods for Automated Sample Preparation for Microorganism Identification and Differentiation
14 Jan 21
Systems and methods for automated biological sample preparation for use in rapid identification and antimicrobial susceptibility testing of microorganisms, such as bacteria and fungi, are provided.
APP
Utility
Instrument and System for Rapid Microorganism Identification and Antimicrobial Agent Susceptibility Testing
25 Nov 20
A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed.
GRANT
Utility
Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
1 Jun 20
A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed.